[{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.8,"TPM_sd":1.89,"TPM_min":1.22,"TPM_25th_percentile":2.67,"TPM_median":3.88,"TPM_75th_percentile":5,"TPM_max":6.14},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.39,"TPM_sd":1.41,"TPM_min":0.93,"TPM_25th_percentile":2.82,"TPM_median":3.04,"TPM_75th_percentile":4.14,"TPM_max":5.85},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 13)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.75,"TPM_sd":19.3,"TPM_min":1.2,"TPM_25th_percentile":2.4,"TPM_median":4.01,"TPM_75th_percentile":17.67,"TPM_max":69.9},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 14)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TCGA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":32.02,"TPM_sd":32.05,"TPM_min":4.4,"TPM_25th_percentile":13.83,"TPM_median":24.12,"TPM_75th_percentile":34.48,"TPM_max":129.29},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 5)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.07,"TPM_sd":2.47,"TPM_min":0.08,"TPM_25th_percentile":0.37,"TPM_median":1.25,"TPM_75th_percentile":2.47,"TPM_max":6.16},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 3)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 1.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.74,"TPM_sd":1.13,"TPM_min":1.02,"TPM_25th_percentile":1.08,"TPM_median":1.15,"TPM_75th_percentile":2.09,"TPM_max":3.04}]